AWM
KDNY

Arbor Wealth Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Arbor Wealth Management’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-300
Closed -$2K – 203
2019
Q2 		$2K Hold
300
– – ﹤0.01% 199
2019
Q1 		$6K Buy
+300
New +$5.23K ﹤0.01% 158

Other funds holding KDNY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Arbor Wealth Management's KDNY Position: Q3 2019 in Review

Arbor Wealth Management sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2019, closing a stake of 300 shares — an estimated $2K sold.

Arbor Wealth Management first reported a position in KDNY in Q1 2019 and held it in 2 quarters. The position peaked at $6K in Q1 2019. 88 funds tracked by Wall St. Rank hold KDNY as of Q3 2019.

  • Arbor Wealth Management reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Arbor Wealth Management sold 300 Chinook Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $2K.
  • Arbor Wealth Management first reported a position in Chinook Therapeutics, Inc. Common Stock in Q1 2019 and held it in 2 quarters.
  • Arbor Wealth Management's Chinook Therapeutics, Inc. Common Stock position peaked at $6K in Q1 2019.
  • 88 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2019.

Based on Arbor Wealth Management's 13F filing for Q3 2019, filed 6 Nov 2019.